SCHEMBL15976014

SCHEMBL15976014

COC(=O)c1cc(Br)nc(-c2ccc(C=O)cc2)c1N=[N+]=[N-]

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
MAPT P10636 2/20 0.34
CYP1A2 P05177 1/20 0.34
HSP90AA1 P07900 1/20 0.34
CYP2C9 P11712 1/20 0.34
HPGD P15428 1/20 0.34
CYP2C19 P33261 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
TACR3 P29371 1/20 0.32
SLC6A3 Q01959 2/20 0.31
RAB9A P51151 1/20 0.31
SLC6A2 P23975 1/20 0.30
SLC6A4 P31645 1/20 0.30
PTGS2 P35354 1/20 0.30
TP53 P04637 1/20 0.30
ERN1 O75460 1/20 0.30
CA12 O43570 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15976015 0.89 ALDH1A1 (0.34) ALDH1A1MAPTCYP1A2HSP90AA1CYP2C9
SCHEMBL15976016 0.87 MAPT (0.43) ALDH1A1MAPTHPGDSMN1; SMN2L3MBTL1
SCHEMBL15976000 0.86 TACR3 (0.41) ALDH1A1MAPTHPGDSMN1; SMN2L3MBTL1
SCHEMBL15800345 0.85 KDR (0.37) ALDH1A1MAPTHPGDL3MBTL1RAB9A
SCHEMBL15800330 0.83 CA12 (0.41) ALDH1A1MAPTCYP2C9HPGDCYP2C19
SCHEMBL15976018 0.82 PDCD1 (0.39) ALDH1A1MAPTSMN1; SMN2L3MBTL1RAB9A
SCHEMBL15976008 0.80 KMO (0.40) ALDH1A1MAPTHPGDSMN1; SMN2L3MBTL1
SCHEMBL15800339 0.80 MAPT (0.41) ALDH1A1MAPTCYP1A2HSP90AA1CYP2C9
SCHEMBL15976013 0.79 MCL1 (0.41) SMN1; SMN2RAB9A
SCHEMBL15976011 0.78 KMT2A (0.42) ALDH1A1MAPTHPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8815840-B2 Carbazole and carboline kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2014-08-26 US disclosed
US-8815840-B2 Carbazole and carboline kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2014-08-26 US disclosed
US-20120058988-A1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2012-03-08 US disclosed
WO-2010080474-A1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120058988-A1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS JAK2, JAK1, JAK3 ALDH1A1 1464/4885MAPT 4508/4885CYP1A2 1040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.